Emicizumab in Acquired Hemophilia A

Clinical trial NCT04188639 · COMPLETED

Trial details

NCT number: NCT04188639
Sponsor: GWT-TUD GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hemophilia A, Acquired

Start date: 2021-03-23
Primary completion: 2023-01-04
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.